摘 要：目的：比较艾迪注射液加肝动脉化疗栓塞(观察组)与单用肝动脉化疗栓塞(对照组)对Ⅱ、Ⅲ期原发性肝癌的临床疗效。方法:观察组68例Ⅱ、Ⅲ期原发性肝癌患者在肝动脉化疗栓塞的同时加用艾迪注射液60ml，溶于生理盐水500ml中，每日一次，连用15d；对照组60例Ⅱ、Ⅲ期原发性肝癌患者单用肝动脉化疗栓塞(TAE)治疗。结果：观察组治疗后及近期疗效及半年生存率跟对照组有显著性差异。(P<0.05)。结论:艾迪注射液与肝动脉化疗栓塞联合应用，疗效显著，可改善患者的生存质量。

    关键词： 肝癌； 艾迪注射液； 肝动脉化疗栓塞

    The Survey of 68 cases with StageⅡ and StageⅢ Hepatoma Treated by Aidi Injection and TAE

    LONG Jian-an, LI Ye-mei

    (Wuyi TCM Hospital of Jiangmen, Guangdong Jiangmen 529000, China)

    Abstract： Objective: This study was designed to evaluate the clinical treatment effect of Aidi injection and TAE versus TAE in cases with stageⅡand stageⅢ hepatic carcinoma. Methods: 68 cases of survey group with stageⅡand stageⅢ underwent TAE, and at the same time combined Aidi injection, which dissolved in 0.9% Ns 500ml for intravenous drip for 15 days and used once a day ; 60 cases of contrast group with stageⅡand stageⅢ hepatic carcinoma underwent TAE only. Result: The effect in the near future and half-year survive rate of the survey group were notably different with that of the contrast group. (P<0.05).Conclusion: Use treatment of ai di injection , which combined TAE, to patients with stageⅡand stageⅢ hepatic carcinoma has notably effect. It can improve the survive quality of the patients. ......